We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KARO:NASDAQKarooooo Ltd. Analysis

Data as of 2026-04-12 - not real-time

$50.75

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Karooooo Ltd. (KARO) is trading at $50.75, comfortably above its 20‑day SMA of 48.43 and 50‑day SMA of 47.96, while the 200‑day SMA sits at 48.39, indicating a modest uptrend despite a neutral overall trend direction. The RSI of 61.5 suggests the stock is not yet overbought, and the MACD histogram remains positive (0.31) with a bullish signal line, supporting short‑term momentum. However, volume is decreasing and the price sits near the midpoint of a support level at 45.08 and resistance at 52.19, implying limited upside in the immediate term. Recent news highlights robust ARR growth and the addition of two million Cartrack subscribers, offset by currency headwinds and higher marketing spend, which may pressure margins in the near term.
Fundamentally, KARO delivers strong profitability – a 33.6% ROE, 19.3% operating margin, and free cash flow of $620 M – while maintaining a low debt‑to‑equity of 19.7% and a healthy cash position. The dividend yield of 4.59% with a 66.8% payout ratio appears sustainable given the cash flow profile. Valuation metrics are attractive: a trailing PE of 25.2 is well below the industry average of 33.9, and analysts’ median target of $59.5 suggests roughly an 18% upside. Combined with a high dividend and strong growth drivers, KARO presents a compelling blend of growth and value characteristics.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD with modest momentum
  • Decreasing volume and proximity to resistance
  • Currency headwinds affecting near‑term earnings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong ROE and operating margins
  • Undervalued relative to industry PE and analyst targets
  • Robust subscriber growth and high dividend yield

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Recurring SaaS revenue model with global footprint
  • Sustainable dividend providing cash return
  • Long‑term upside potential from market expansion despite volatility

Key Metrics & Analysis

Financial Health

Revenue Growth21.60%
Profit Margin19.47%
P/E Ratio25.2
ROE33.58%
ROA18.27%
Debt/Equity19.66
P/B Ratio8.3
Op. Cash Flow$1.7B
Free Cash Flow$620.3M
Industry P/E33.9

Technical Analysis

TrendNeutral
RSI61.5
Support$45.08
Resistance$52.19
MA 20$48.43
MA 50$47.96
MA 200$48.39
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$654.78
Target Price$60.17
Upside/Downside18.56%
GradeUndervalued
TypeBlend
Dividend Yield4.59%

Risk Assessment

Beta1.15
Volatility30.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.